I urge all of my colleagues on this subcommittee to support these four bills before us today.

Where we do not and we will never agree is on the idea that forcing companies to accept whatever price the government feels like paying for prescription medications is the correct way to lower the cost of prescription medications.

The bill punishes our innovators and undermines the significant strides of this committee.

Even the former Chair of the White House Counsel of Economic Advisors in the Obama administration is sounding alarm bells on inflation by stating that the Biden administration's officials are systematically underestimating inflation.

This past year several indicators have shown the Biden administration is moving the country in the wrong direction.

I want to mention how important it is for the Biden administration to keep crucial components of the Trump administration era.

Americans are experiencing the highest levels of inflation in over 30 years.

Make no mistake. This is not a negotiation. This is government price setting.

However, we cannot talk about advancing healthcare innovation without addressing the harmful drug pricing provision the Democrats' reckless tax and spending spree bill that will ultimately restrict patients' access to timely care and lead to less cures.

I am deeply concerned about the estimated loss of more than 100 new cures if Build Back Better is signed into law and hope this bill ultimately fails.

We lost 100,000 Americans last year to drug overdoses.